List view / Grid view
Abbott announced that it will sell its developed markets branded…
14 July 2014 | By Abbott
Abbott announced that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded company...
A proposed strategic alliance with Fonterra to develop dairy farms…
11 July 2014 | By Abbott
A proposed strategic alliance with Fonterra to develop dairy farms is the latest in a series of investments Abbott has made in China...
Abbott was recognized by The Deal as the best all-around…
18 November 2013 | By Abbott
Abbott was recognized by The Deal as the best all-around dealmaker in healthcare...
Abbott has completed the separation of its research-based pharmaceuticals business...
2 January 2013 | By Abbott
Abbott has completed the separation of its research-based pharmaceuticals business...
Abbott board of directors approved the separation of its research-based…
28 November 2012 | By Abbott
Abbott board of directors approved the separation of its research-based pharmaceuticals business...
AbbVie the new, independent research-based pharmaceutical company...
21 March 2012 | By Abbott
AbbVie the new, independent research-based pharmaceutical company...
Abbott plans to separate into two companies, one in diversified…
19 October 2011 | By Abbott
Abbott plans to separate into two companies, one in diversified medical products & the other in research-based pharmaceuticals...
Abbott announced that Miles D. White has been elected to…
19 April 2011 | By Abbott
Abbott announced that Miles D. White has been elected to the American Academy of Arts and Sciences...
